Response to Ibudilast treatment according to progressive multiple sclerosis disease phenotype

Goodman AD, Fedler JK, Yankey J, Klingner EA, Ecklund DJ, Goebel CV, Bernel RA, Chase M, Coffey CS, Klawiter EC, Naismith RT, Fox RJ on behalf of the SPRINT-MS Investigators.